Back

The administration of valproic acid exerts a protective effect by reducing the infarct size and the triggering of ventricular fibrillation in an experimental model of chronic myocardial infarction

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Targeting remodeling of the injured heart Ischaemia, Infarction, Cardioprotection ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Miss Patricia Genoves

University of Valencia, Valencia (Spain)

4 More presentations in this session

Presentation thumbnail
The regenerative response of cardiac interstitial cells
Doctor C. Jopling (Montpellier, FR)
Abstract Slides
Presentation thumbnail
Deficiency of pituitary adenylate cyclase-activating peptide and its receptor PAC1 confers interstitial cardiac fibrosis in a murine model of metabolic stress
Mr J. Schubart (Kassel, DE)
Abstract Slides
Presentation thumbnail
Cardiac sympathetic afferent denervation reduces matrix metalloproteinase expression and improves cardiac remodeling in rats post myocardial infarction
Professor I. Zucker (Omaha, US)
Abstract Slides
Presentation thumbnail
Human epididymis protein 4 indicates progression of cardiac fibrosis in Heart Failure with preserved Ejection Fraction.
Doctor N. Nakashima (Kumamoto, JP)
Abstract Slides

Access the full session

Session thumbnail
Targeting remodeling of the injured heart

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources